Mercy Health Research

Mercy Health Research is the clinical and translational research arm of Mercy Health Australia, a major Catholic healthcare provider specializing in maternal-fetal medicine and aged care. The organization is globally recognized for its "Mercy Perinatal" center, which operates a sophisticated drug discovery and repurposing pipeline aimed at treating life-threatening pregnancy complications. By identifying existing medications with potential efficacy in obstetric conditions, Mercy Health Research has advanced several candidates from laboratory screening to international multi-center clinical trials. Key programs include the evaluation of esomeprazole and metformin for preeclampsia and a novel gefitinib-methotrexate combination for the medical management of ectopic pregnancy.